Amgen INC AMGEN ORD (CDI)
Amgen INC AMGEN ORD (CDI)/ US0311621009 /
0R0T
2024. 04. 25. 19:06:01
|
Vált.
-
|
Forgalom (db) |
Vétel17:35:23 |
Eladás17:35:23 |
Piaci kapitalizáció |
Osztalékh. |
P/E Ráta |
268,25USD
|
-
|
2 462 Forgalom: 173 778,10 |
-Vétel (db): - |
-Eladás (db): - |
172,03 mrd.USD |
2,70% |
25,49 |
Cégbemutató
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Igazgatóság & Felügyelőbizottság
CEO |
Robert Bradway |
Igazgatóság |
Peter H. Griffith, Annalisa Pizzarello, Anton Rabushka, Arleen Paulino, Darryl Sleep, David A. Piacquad, David M. Reese, Esteban Santos, Gilles Marrache, Ian Thompson, Jean-Charles Soria, Jerry Murry, Jonathan Graham, Judy Gawlik Brown, Lori Johnston, Mark J. Taisey, Mike Zahigian, Murdo Gordon, Nancy Grygiel, Rachna Khosla, Raymond Deshaies, Rob Lenz, Susan Sweeney, Victoria H. Blatter |
Felügyelőbizottság |
Robert A. Bradway, Amy E. Miles, Brian J. Druker, Charles M. Holley Jr., Ellen J. Kullman, Greg C. Garland, Michael V. Drake, R. Sanders Williams, Robert A. Eckert, Ronald D. Sugar, S. Omar Ishrak, Tyler Jacks, Wanda M. Austin |
Cégadat
Név: |
Amgen Inc. |
Cím: |
One Amgen Center Drive,Thousand Oaks, CA 91320-1799, USA |
Telefon: |
+1-805-447-1000 |
Fax: |
+1-805-447-1010 |
E-mail: |
investor.relations@amgen.com
|
Internet: |
www.amgen.com |
Ipar: |
Gyógyászat |
Szektor: |
Orvosi termékek |
Alszektor: |
Fejlett gyógyászati berendezések |
Pénzügyi év vége: |
12. 31. |
Közkézhányad: |
76,20% |
IPO dátum: |
1983. 06. 17. |
Cégnaptár
Naptár 47 | 2024. 11. 18.
Osztalék megállapításának napja
|
Naptár 47 | 2024. 11. 18.
Ex-Dividend
|
Naptár 50 | 2024. 12. 09.
Osztalékok
|
Fő részvényesek
Egyéb |
|
71,83% |
Vanguard Group Inc |
|
9,15% |
State Street Corp |
|
5,50% |
Primecap Management Co/Ca/ |
|
2,72% |
Morgan Stanley |
|
2,69% |
Geode Capital Management, Llc |
|
2,30% |
Charles Schwab Investment Management Inc |
|
1,94% |
Wells Fargo & Company/Mn |
|
1,40% |
Capital Research Global Investors |
|
1,25% |
Egyéb |
|
1,22% |